meta content='width=device-width, initial-scale=1.0' name='viewport'/>

Wednesday, April 25, 2018

THE TREATMENT OF CANCER, AUTISM, INFLAMMATION, VIRAL AND BACTERIAL DISEASE BY GcMAF


Nagalase blocks GcMAF production by deglycosylating Vitamin D-Binding Protein

Nagalase blocks GcMAF production by deglycosylating Vitamin D-Binding Protein



Human GcMAF, otherwise known as Vitamin D binding protein-macrophage activating factor, holds great promise in the treatment of various illnesses including cancer, autism, chronic fatigue and possibly Parkinson's. Since 1990, 59 research papers have been published on GcMAF, 20 of these pertaining to the treatment of cancer.




46 of these papers can be accessed through the GcMAF web site. GcMAF is a vital part of our immune system which does not work without it and is part of our blood. GcMAF stimulates the macrophage element of the immune system to destroy cancer cells.

It also blocks the supply of nutrients to cancer cells by stopping blood vessel development to the site (anti-angiogenesis). Cancer cells are weakened and starved, making them more vulnerable to attack by the GcMAF stimulated macrophage system.

Research has shown macrophage activation and stopping diseased blood vessel development can also help in various neurological diseases such as Parkinson's, Alzheimer's, rheumatoid arthritis, inflammatory conditions, and diabetic retinopathy.

In the case of autism, Dr. James Bradstreet has so far treated 1,100 patients with GcMAF with an 85% response rate. His results show a bell curve response with 15% of the patients showing total eradication of symptoms and 15% showing no response.

In addition, experimental and clinical evidence confirms that GcMAF shows multiple powerful anti-cancer effects that have a significant therapeutical impact on most tumors including breast, prostate, and kidney. GcMAF is created in the body by the release of two sugar molecules from a GcProtein molecule.

However, tumors release an enzyme known as Nagalase. Nagalase degrades GcProtein to the point it is unable to become GcMAF. Since GcMAF only lives for about a week in the body, without continuous conversion of GcProtein the stores of GcMAF are depleted rapidly in the presence of Nagalase. However, Nagalase can only destroy GcProtein and not GcMAF.

Thus the introduction of external GcMAF through injection into the body has been shown to be effective. GcMAF has no side effects of its own, but in under 10% of cases the immune system, which will be rebuilt in just three weeks, can produce considerable side effects in autistic children.

The treatment consists of an injection with a tiny diabetic sized syringe once a week. The duration depends on the severity of the disease. Research also reveals that in cancer cases that are stage I and II, the success rate approaches 90% inside 6 months.

Nagalase and immune system levels can be measured in the blood and thus offer a marker for cancer and other diseases. In conclusion, GcMAF restores the energetic balance in the cell. Cancer cells are driven by sugar metabolism become healthy oxygen driven cells, so tumor cells no longer behave as parasitic organisms.

GcMAF stimulates macrophages to consume the cancer cells and cells invaded by viruses. This stimulation of the immune system and the anti-angiogenetic effect surrounding the tumor is beneficial in cancer and several neurological disorders like autism, chronic fatigue, Parkinson's, and Alzheimer's, and it is available to the general public.'

http://www.faim.org/autism/gcmaf-treatment-cancer-autism-inflammation-viral-bacterial-disease.html

Dr. Bradstreet, Nagalase, and the Viral Issue in Autism by Kent Heckenlively Oct 2011 I was intrigued by his October 11, 2011 entry, "An Update on Viral Issue in Autism" since it dovetailed with some of my own recent investigations.

[This article was located on Dr. Bradstreet's internet site, but it has since been mysteriously removed: 

http://drbradstreet.org/2011/10/11/an-update-on-viral-issue-in-autism/] ...'

In the past months Dr. Bradstreet has become interested in nagalese, which he describes as an enzyme "produced by cancer cells and viruses."

He thinks it unlikely that children with autism have undiagnosed cancers, and thus suspicion falls on a viral etiology. Dr. Bradstreet writes, "Viruses make the nagalese enzyme as part of their attachment proteins. 

It serves to get the virus into the cell and also decreases the body's immune reaction to the virus-thereby increasing the odds of viral survival.

Further on Dr. Bradstreet writes, "It is reasonable and likely that the nature of the immune dysfunction and the frequently observed autoimmune problems in autism are mediated by persistent, unresolved viral infections."

He claims to have tested approximately 400 children with autism for the viral marker, nagalese, and found that nearly 80% have significantly elevated levels. 

He hopes to publish soon on this study and believes this information "is one of the most important developments in the clinical treatment of children on the spectrum that I have experienced in the last 15 years."

http://www.wellsphere.com/autism-autism-spectrum-article/dr-bradstreet-nagalase-and-the-viral-issue-inautism/1531748
http://www.ageofautism.com/2011/10/dr-bradstreet-nagalase-and-the-viral-issue-in-autism.html

The bad law kills, and Britain has the worst medical laws in Europe. The 1939 Cancer Act makes it illegal to discuss the possibility cancer can be cured, which is partly why 160,000 people die unnecessarily of cancer in Britain every year.

There are 142 eminent scientists who have published GcMAF research papers on the US National Library of Medicine alone. 

https://gcmaf.se/ 

Regulator warns against GcMAF made in an unlicensed facility in GcMAF (Globulin component Macrophage Activating Factor), a blood product, claims to treat a range of conditions including cancer, HIV, and autism.

https://www.gov.uk/ government/ news/ regulator-warns-against-gcmaf-made-in-unlicensed-facility-in cambridgeshire


By David Noakes

1 comment:

  1. Your style is really unique in comparison to other people I have read stuff from.
    Thanks for posting when you have the opportunity,
    Guess I will just bookmark this blog.

    ReplyDelete